New device takes on stubborn nail fungus in Head-to-Head trial
NCT ID NCT06689852
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study compares a new medical device called ENRICHED to a standard nail fungus treatment (Loceryl) in 88 adults with nail fungus. Participants will use one of the two treatments for 9 months. Doctors will measure how much healthy nail grows back by analyzing photos. The goal is to see if the new device is safe and works better than the current option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ENRICHED (X92001591) medical device and Loceryl 5% (amorolfine) nail lacquer
- What this could lead to
- If successful, this could provide a new, effective treatment option for nail fungus infections.
- What could go wrong
- This is a small, early-stage trial with only 88 participants. The new device may not work better than the existing treatment, and results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONYCHOMYCOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Eurofins Dermscan Pharmascan
RECRUITINGVilleurbanne, France, 69100, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.